Top compounds associated with response to TMPO


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.19 8e-05
mRNA tivozanib CTRPv2 pan-cancer AAC -0.024 0.5
mRNA tivozanib GDSC1000 pan-cancer AAC 0.0028 0.9
mRNA tosedostat CTRPv2 pan-cancer AAC 0.081 0.04
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.038 0.3
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.004
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.077 0.06
mRNA triptolide CTRPv2 pan-cancer AAC 0.034 0.4
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.11 0.03
Download CSV